company background image
300633 logo

SonoScape Medical SZSE:300633 Stock Report

Last Price

CN¥31.97

Market Cap

CN¥14.0b

7D

-7.7%

1Y

-24.0%

Updated

21 Aug, 2024

Data

Company Financials +

SonoScape Medical Corp.

SZSE:300633 Stock Report

Market Cap: CN¥14.0b

300633 Stock Overview

Engages in the research and development, production, and sales of medical diagnosis and treatment equipment in China and internationally.

300633 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends3/6

SonoScape Medical Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SonoScape Medical
Historical stock prices
Current Share PriceCN¥31.97
52 Week HighCN¥52.30
52 Week LowCN¥31.61
Beta-0.35
11 Month Change-15.29%
3 Month Change-21.35%
1 Year Change-24.01%
33 Year Change-1.45%
5 Year Change15.00%
Change since IPO324.57%

Recent News & Updates

Recent updates

Returns On Capital Signal Tricky Times Ahead For SonoScape Medical (SZSE:300633)

Aug 18
Returns On Capital Signal Tricky Times Ahead For SonoScape Medical (SZSE:300633)

Is SonoScape Medical Corp. (SZSE:300633) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 17
Is SonoScape Medical Corp. (SZSE:300633) Expensive For A Reason? A Look At Its Intrinsic Value

Does SonoScape Medical (SZSE:300633) Have A Healthy Balance Sheet?

Jun 13
Does SonoScape Medical (SZSE:300633) Have A Healthy Balance Sheet?

Pinning Down SonoScape Medical Corp.'s (SZSE:300633) P/E Is Difficult Right Now

May 22
Pinning Down SonoScape Medical Corp.'s (SZSE:300633) P/E Is Difficult Right Now

We Think SonoScape Medical (SZSE:300633) Can Manage Its Debt With Ease

Mar 12
We Think SonoScape Medical (SZSE:300633) Can Manage Its Debt With Ease

An Intrinsic Calculation For SonoScape Medical Corp. (SZSE:300633) Suggests It's 41% Undervalued

Feb 28
An Intrinsic Calculation For SonoScape Medical Corp. (SZSE:300633) Suggests It's 41% Undervalued

Shareholder Returns

300633CN Medical EquipmentCN Market
7D-7.7%-3.4%-1.6%
1Y-24.0%-14.7%-18.6%

Return vs Industry: 300633 underperformed the CN Medical Equipment industry which returned -14.7% over the past year.

Return vs Market: 300633 underperformed the CN Market which returned -18.6% over the past year.

Price Volatility

Is 300633's price volatile compared to industry and market?
300633 volatility
300633 Average Weekly Movement5.4%
Medical Equipment Industry Average Movement5.2%
Market Average Movement5.5%
10% most volatile stocks in CN Market8.9%
10% least volatile stocks in CN Market3.7%

Stable Share Price: 300633's share price has been volatile over the past 3 months.

Volatility Over Time: 300633's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20022,697Kunxiang Wuwww.sonoscape.com

SonoScape Medical Corp. engages in the research and development, production, and sales of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, gastroenterology, pulmonology, and endoscopic products. It also provides technical and spare parts support, training, upgradation, and field services, as well as MIS solutions.

SonoScape Medical Corp. Fundamentals Summary

How do SonoScape Medical's earnings and revenue compare to its market cap?
300633 fundamental statistics
Market capCN¥13.97b
Earnings (TTM)CN¥416.15m
Revenue (TTM)CN¥2.13b

33.1x

P/E Ratio

6.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300633 income statement (TTM)
RevenueCN¥2.13b
Cost of RevenueCN¥682.40m
Gross ProfitCN¥1.44b
Other ExpensesCN¥1.03b
EarningsCN¥416.15m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)0.96
Gross Margin67.91%
Net Profit Margin19.57%
Debt/Equity Ratio7.7%

How did 300633 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

33%

Payout Ratio